The latest closing stock price for Alnylam Pharmaceuticals as of May 29, 2025 is 292.90.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $47,735 today, roughly 48 times their original investment - a 20.33% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 3.9% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 49.7% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 253.34.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $47,735 today, roughly 48 times their original investment - a 20.33% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 3.9% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 49.7% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 253.34.